RU2019123695A - Способы, массивы и их применение - Google Patents

Способы, массивы и их применение Download PDF

Info

Publication number
RU2019123695A
RU2019123695A RU2019123695A RU2019123695A RU2019123695A RU 2019123695 A RU2019123695 A RU 2019123695A RU 2019123695 A RU2019123695 A RU 2019123695A RU 2019123695 A RU2019123695 A RU 2019123695A RU 2019123695 A RU2019123695 A RU 2019123695A
Authority
RU
Russia
Prior art keywords
weeks
biomarkers
pancreatic cancer
binding
paragraphs
Prior art date
Application number
RU2019123695A
Other languages
English (en)
Russian (ru)
Inventor
Карл БОРРЕБАЕК
Линда Декслин МЕЛЛБИ
Андреас НИБЕРГ
Кристер ВИНГРЕН
Original Assignee
Иммуновиa Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иммуновиa Аб filed Critical Иммуновиa Аб
Publication of RU2019123695A publication Critical patent/RU2019123695A/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Gastroenterology & Hepatology (AREA)
RU2019123695A 2017-01-31 2018-01-31 Способы, массивы и их применение RU2019123695A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1701572.8 2017-01-31
GBGB1701572.8A GB201701572D0 (en) 2017-01-31 2017-01-31 Methods, arrays and uses thereof
PCT/EP2018/052423 WO2018141804A1 (en) 2017-01-31 2018-01-31 Methods, arrays and uses thereof

Publications (1)

Publication Number Publication Date
RU2019123695A true RU2019123695A (ru) 2021-03-02

Family

ID=58462729

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019123695A RU2019123695A (ru) 2017-01-31 2018-01-31 Способы, массивы и их применение

Country Status (13)

Country Link
US (1) US20190382849A1 (https=)
EP (1) EP3577464A1 (https=)
JP (1) JP2020507760A (https=)
KR (1) KR20190109422A (https=)
CN (1) CN110325860A (https=)
AU (1) AU2018214180A1 (https=)
BR (1) BR112019015633A2 (https=)
CA (1) CA3051968A1 (https=)
GB (1) GB201701572D0 (https=)
IL (1) IL268244A (https=)
MX (1) MX2019008911A (https=)
RU (1) RU2019123695A (https=)
WO (1) WO2018141804A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681899C (en) 2007-03-27 2018-06-19 Immunovia Ab Methods for diagnosis of pancreatic adenocarcinoma, and biomarkers and arrays for use in the same
US12441802B2 (en) 2019-07-03 2025-10-14 Crystal Bioscience Inc. Anti-B7-H3 antibody and methods of use thereof
KR102289278B1 (ko) * 2019-07-09 2021-08-13 주식회사 베르티스 췌장암 진단용 바이오마커 패널 및 그 용도
JP7822313B2 (ja) * 2019-12-20 2026-03-02 メディミューン，エルエルシー グリピカン３を標的とするキメラ抗原受容体を用いて癌を治療する組成物及び方法
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
JP2024511189A (ja) * 2021-03-26 2024-03-12 ビオンテック・ソシエタス・エウロパエア がんの処置における抗ｃａ１９－９抗体およびｆｏｌｆｉｒｉｎｏｘを用いた組合せ療法。
CN113336851B (zh) * 2021-06-30 2021-12-24 徐州医科大学 新型全人源抗人b7h3抗体、包含所述抗体的组合物及其应用
CN120177800B (zh) * 2025-05-23 2025-10-10 四川大学 血液生物标志物cfp在制备急性胰腺炎诊断试剂的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US8632983B2 (en) * 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
CA2681899C (en) 2007-03-27 2018-06-19 Immunovia Ab Methods for diagnosis of pancreatic adenocarcinoma, and biomarkers and arrays for use in the same
CN106706914B (zh) * 2010-09-09 2018-10-19 北京同为时代生物技术有限公司 用于诊断上皮源性癌症的血液标志物及单克隆抗体
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201206323D0 (en) * 2012-04-10 2012-05-23 Immunovia Ab Methods and arrays for use in the same
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
GB201516801D0 (en) * 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof

Also Published As

Publication number Publication date
EP3577464A1 (en) 2019-12-11
CN110325860A (zh) 2019-10-11
WO2018141804A1 (en) 2018-08-09
IL268244A (en) 2019-09-26
CA3051968A1 (en) 2018-08-09
MX2019008911A (es) 2019-09-26
BR112019015633A2 (pt) 2020-03-17
KR20190109422A (ko) 2019-09-25
JP2020507760A (ja) 2020-03-12
US20190382849A1 (en) 2019-12-19
AU2018214180A1 (en) 2019-08-08
GB201701572D0 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
RU2019123695A (ru) Способы, массивы и их применение
TWI708058B (zh) 阿茲海默症及其他神經退化性疾病之生物標記及診斷方法
KR101032607B1 (ko) 간암 진단용 단백질성 마커
KR101073875B1 (ko) 대장암 진단 마커 및 이를 이용한 대장암 진단방법
RU2018138639A (ru) Способ, чип и их применение
US20070292869A1 (en) Compositions and Methods for Analyzing Renal Cancer
KR20160045547A (ko) 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
KR102068822B1 (ko) 질환의 진단용 조성물
KR102547531B1 (ko) 주요 우울 장애 치료 반응성 평가용 바이오마커
KR20130046457A (ko) 신규한 대장암 진단용 마커 및 이를 이용한 대장암 진단 키트
KR100925147B1 (ko) 폐암 진단용 마커
EP2652505A2 (en) Methods of diagnosing and treating pancreatic cancer
JP6639408B2 (ja) デオキシハイプシン・シンターゼ遺伝子を指標として用いる動脈硬化及びがんの検出方法
US20150338412A1 (en) Composition for diagnosis of lung cancer and diagnosis kit for lung cancer
CN114058700A (zh) Rbm10基因的用途
KR101657051B1 (ko) 만성폐쇄성폐질환 진단용 마커 조성물
KR20240009366A (ko) 초기 알츠하이머병 진단용 바이오마커 및 이의 용도
EP2772759A1 (en) Composition for diagnosis of lung cancer
CN113785200B (zh) 基于过表达tuba1c蛋白的外泌体的标志物组合物
JP6004369B2 (ja) 糖尿病合併症マーカーとなり得る新規ｒａｇｅリガンド
KR20170100213A (ko) 신장암 진단용 조성물과 진단 마커 검출 방법
US20130225437A1 (en) Biomarkers of cancer
KR102533728B1 (ko) 뇌 유래 엑토좀 특이적 마커와 다중 마커군의 발현 패턴을 이용한 비침습성 치매 진단 방법
KR101054953B1 (ko) 간암을 진단 및 치료하기 위한 분자인 ｓｎｘ１４, 그를 포함하는 키트
KR100899848B1 (ko) 폐암 진단용 마커

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20210201